Evidence map›Paper›PMID 26405811›Full record

ArticlePloS one2015

Targeted Knock-Down of miR21 Primary Transcripts Using snoMEN Vectors Induces Apoptosis in Human Cancer Cell Lines.

Motoharu Ono, Kayo Yamada, Fabio Avolio, Vackar Afzal, Dalila Bensaddek, Angus I Lamond

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. SnoRNAs: The promising targets for anti-tumor therapy.Journal of pharmaceutical analysis · 2024
    Review
  2. Review
  3. Article
  4. Functional diversity of small nucleolar RNAs.Nucleic acids research · 2020
    Article
  5. Article
  6. Nuclear microRNAs in normal hemopoiesis and cancer.Journal of hematology & oncology · 2017
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Motoharu OnoCentre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Kayo YamadaCentre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Fabio AvolioCentre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Vackar AfzalCentre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Dalila BensaddekCentre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Angus I LamondCentre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
University of Dundee · GB

Funding

Medical Research Council G0801738Wellcome Trust 073980Wellcome Trust 097945
6 · The paper itself

Abstract

We have previously reported an antisense technology, 'snoMEN vectors', for targeted knock-down of protein coding mRNAs using human snoRNAs manipulated to contain short regions of sequence complementarity with the mRNA target. Here we characterise the use of snoMEN vectors to target the knock-down of micro RNA primary transcripts. We document the specific knock-down of miR21 in HeLa cells using plasmid vectors expressing miR21-targeted snoMEN RNAs and show this induces apoptosis. Knock-down is dependent on the presence of complementary sequences in the snoMEN vector and the induction of apoptosis can be suppressed by over-expression of miR21. Furthermore, we have also developed lentiviral vectors for delivery of snoMEN RNAs and show this increases the efficiency of vector transduction in many human cell lines that are difficult to transfect with plasmid vectors. Transduction of lentiviral vectors expressing snoMEN targeted to pri-miR21 induces apoptosis in human lung adenocarcinoma cells, which express high levels of miR21, but not in human primary cells. We show that snoMEN-mediated suppression of miRNA expression is prevented by siRNA knock-down of Ago2, but not by knock-down of Ago1 or Upf1. snoMEN RNAs colocalise with Ago2 in cell nuclei and nucleoli and can be co-immunoprecipitated from nuclear extracts by antibodies specific for Ago2.

Indexed as

AdenocarcinomaAdenocarcinoma of LungApoptosisArgonaute ProteinsEukaryotic Initiation FactorsGene Knockdown TechniquesGenetic VectorsHEK293 CellsHeLa CellsHumansLentivirusLung NeoplasmsMicroRNAsPlasmidsRNA, AntisenseRNA HelicasesAGO1 protein, humanAGO2 protein, humanArgonaute ProteinsEukaryotic Initiation FactorsMicroRNAsMIRN21 microRNA, humanRNA, AntisenseRNA HelicasesRNA PrecursorsTrans-ActivatorsUPF1 protein, human

Identifiers

PMID26405811
PMCPMC4583369
OpenAlexW2204379715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.